SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-071200
Filing Date
2023-06-14
Accepted
2023-06-14 16:15:13
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES VII, INC.ATLAS VENTURE ASSOCIATES VII, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2318695d1_sc13da.htm SC 13D/A 72075
  Complete submission text file 0001104659-23-071200.txt   73970
Mailing Address 56 WAREHAM STREET, FLOOR 3 BOSTON MA 02118
Business Address 56 WAREHAM STREET, FLOOR 3 BOSTON MA 02118 617-588-2694
Atlas Venture Fund VII L P (Filed by) CIK: 0001346450 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88625 | Film No.: 231014278
SIC: 8071 Services-Medical Laboratories